UK cost agency turns down Sanofi bowel cancer drug
LONDON (Reuters) - Sanofi's new bowel cancer drug Zaltrap is not worth using on Britain's state health service given its high price, the country's hea...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/Uq_qukhYQ7k/story01.htm
No comments:
Post a Comment